10-Q: 22nd Century Group Q3: Revenue Drops, Net Income Up on Settlement

22nd Century Group reported a significant net income increase in Q3 2025 driven by an insurance settlement, despite a 32.5% decline in net revenue from continuing operations and ongoing going concern doubts.

Summary

• Net income for Q3 2025 was $5,489 thousand, a significant improvement from a net loss of $3,757 thousand in Q3 2024, primarily due to $9,252 thousand income from discontinued operations related to an insurance settlement.
• Net loss for the nine months ended September 30, 2025, was $2,246 thousand, a substantial reduction from a net loss of $10,608 thousand in the prior year period.
• Net revenues from continuing operations for Q3 2025 decreased by 32.5% to $4,011 thousand, compared to $5,946 thousand in Q3 2024, mainly due to shifts in product mix and pricing adjustments.
• Year-to-date net revenues from continuing operations decreased by 31.0% to $14,050 thousand, from $20,361 thousand in the prior year.
• Gross loss increased by 80.1% to $1,059 thousand in Q3 2025 and by 100.8% to $2,303 thousand for the nine months ended September 30, 2025, compared to prior year periods.
• Operating loss from continuing operations improved slightly by 4.9% to $3,212 thousand in Q3 2025 and by 11.1% to $8,763 thousand for the nine months ended September 30, 2025.
• Cash and cash equivalents stood at $4,846 thousand as of September 30, 2025.
• Working capital from continuing operations increased significantly to $12,711 thousand as of September 30, 2025, from $1,790 thousand at December 31, 2024, largely due to the recognition of $9,500 thousand in insurance recoveries.
• The company fully repaid and terminated its Senior Secured Credit Facility, including Debentures, on September 18, 2025, using proceeds from a Series A convertible preferred stock offering.
• Basic income per common share was $1.55 for Q3 2025, a significant improvement from a loss of $1,760.26 in Q3 2024. Diluted loss per common share was $0.28 for Q3 2025, also a significant improvement from a loss of $1,760.26 in Q3 2024.

Sentiment

Score: 4

Explanation: While the company achieved net income in Q3 due to a significant insurance settlement and successfully repaid its senior secured debt, its core revenue from continuing operations declined substantially, and gross losses increased. The persistent "going concern" doubt and ongoing need for capital raises, which cause significant dilution, indicate underlying operational and financial challenges.

Positives

• Achieved net income of $5,489 thousand in Q3 2025, a significant turnaround from a net loss in the prior year, primarily due to a $9,500 thousand insurance settlement.
• Successfully repaid and terminated the Senior Secured Credit Facility and Debentures on September 18, 2025, reducing long-term debt obligations.
• Working capital from continuing operations increased substantially to $12,711 thousand as of September 30, 2025, from $1,790 thousand at December 31, 2024.
• Operating expenses (SG&A and R&D) decreased in both the three and nine-month periods ended September 30, 2025, reflecting cost-saving initiatives.
• Cigarette volume increased to 345 cartons in Q3 2025 and 1,370 cartons year-to-date, reflecting additional CMO cigarette customers.
• VLN cigarette net revenues started reflecting partner shipments for initial stocking orders in Q3 2025, with a full-scale launch in over 1,700 c-stores expected in Q4 2025.
• Court granted the company's Special Motion to Strike two out of three counts in the Cookies Retail Products dispute, leaving only a breach of contract claim.

Negatives

• Net revenues from continuing operations decreased by 32.5% in Q3 2025 and 31.0% year-to-date, indicating a decline in core business sales.
• Gross loss increased by 80.1% in Q3 2025 and 100.8% year-to-date, reflecting worsening profitability at the gross margin level.
• Cash used in operating activities increased to $10,472 thousand for the nine months ended September 30, 2025, from $9,947 thousand in the prior year, indicating higher cash burn from operations.
• Interest expense increased by 71.7% in Q3 2025, primarily due to non-cash interest amortization and extinguishment charges.
• The company recorded a $500 thousand provision for credit loss for the 2023 GVB Promissory Note due to default and continues to maintain an allowance for credit loss against the new 2025 GVB Promissory Note.
• Significant dilution occurred due to the issuance of common stock and warrants, with weighted average common shares outstanding increasing substantially.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern through one year following the date of issuance due to significant losses and negative cash flows from operations.
• There is no assurance that the company will be able to raise the capital it needs to continue operations, potentially requiring liquidation of inventory/assets, curtailment of operations, or bankruptcy protection.
• Risks associated with unsuccessful commercialization strategy and launch plans for products or lack of market acceptance of the company's products.
• Challenges in protecting proprietary technology.
• Ongoing legal proceedings, including a breach of contract claim with Cookies Retail Products and an employee dispute related to the Grass Valley fire, could result in material adverse effects.
• Significant portion of revenue derived from a few key customers (e.g., Customer A accounted for 51.94% of Q3 2025 revenue), posing customer concentration risk.
• The volatility of the company's common stock is a stated risk factor.

Future Outlook

The company expects to incur additional losses until it can generate significant revenue and profit in its tobacco business. A full-scale launch of VLN cigarettes in over 1,700 c-stores is expected to begin in the fourth quarter of 2025. Management is actively evaluating strategies to reduce expenses and pursue financing, including debt or equity issuance, asset sales, and strategic partnerships, to address the going concern doubt.

Management Comments

• "Management continues to evaluate different strategies for reducing expenses, as well as pursuing financing strategies which include raising additional funds through the issuance of debt or equity securities, asset sales, and through arrangements with strategic partners."
• "If capital is not available to the Company when, and in the amounts needed, it could be required to liquidate inventory, cease or curtail operations, or seek protection under applicable bankruptcy laws or similar state proceedings."
• "Managements plans do not alleviate substantial doubt about the Companys ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued."
• "In the third quarter of 2025, management implemented further cost savings initiatives of our manufacturing operations to align to our higher margin branded products and VLN cigarettes, as well as forecasted volume, to drive margin improvement."

Industry Context

22nd Century Group operates in the tobacco industry, focusing on harm reduction with its FDA-authorized Modified Risk Tobacco Product (MRTP) VLN cigarette. The broader industry faces increasing regulatory scrutiny and a shift towards reduced-harm products. The company's strategy to focus on higher-margin branded products and VLN cigarettes aligns with this trend, but it faces challenges in commercialization and market acceptance against established players. Its contract manufacturing operations provide a revenue stream but are subject to pricing pressures and product mix shifts.

Comparison to Industry Standards

• The company's focus on reduced nicotine content (RNC) tobacco products, particularly the FDA MRTP authorized VLN cigarette, positions it uniquely in the tobacco industry, differentiating it from traditional tobacco companies like Altria or British American Tobacco, which primarily focus on conventional cigarettes or other reduced-risk products like e-cigarettes or heated tobacco.
• The significant decline in net revenues from continuing operations (32.5% in Q3 2025) and increasing gross losses are concerning compared to the generally stable or slowly declining revenue trends of major tobacco companies, which often offset volume declines with price increases or growth in next-generation products.
• The persistent "going concern" doubt is a critical red flag, indicating financial instability far below industry standards for publicly traded companies, which typically maintain robust liquidity and profitability.
• The substantial dilution from warrant exercises and preferred stock offerings, while providing necessary capital, is a common characteristic of early-stage or distressed companies, not established industry leaders.
• The company's cost-saving initiatives and shift towards higher-margin branded products are standard strategic responses to revenue pressures, but their effectiveness in achieving profitability remains to be seen.

Corporate Governance

Legal Proceedings

• Insurance Litigation (Dorchester Insurance Company, Ltd.): Resolved for $9,500 thousand cash settlement on September 18, 2025, related to the November 2022 Grass Valley manufacturing facility fire. Payment received on October 29, 2025.
• Cookies Retail Products, LLC (CRP) Dispute: Complaint filed October 23, 2024, alleging Breach of Contract, Fraud, and Violation of Penal Code Section 496. On April 28, 2025, the court granted the company's motion to strike the fraud and penal code counts, leaving only the breach of contract claim. Discovery is ongoing.
• Employee Dispute: Complaint filed November 19, 2024, by a former employee related to the November 2022 Grass Valley fire, alleging Premises Liability, Personal Injury, and Negligence. The company has moved to dismiss all counts and intends to vigorously defend itself.

Related Party Transactions

• Generated revenue from a related party contract manufacturing customer beginning in Q4 2024. Private label cigarette revenue and corresponding contract asset from this related party were not material during the three and nine months ended September 30, 2025. The arrangement was terminated in April 2025.
• Entered into a new 2025 GVB Promissory Note with GVB Biopharma (a former subsidiary) for $500 thousand on September 18, 2025, payable in installments. The company continues to maintain an allowance for credit loss against this note.

Stakeholder Impact

• Shareholders: Experienced significant dilution due to multiple capital raises involving common stock, preferred stock, and warrants. The "going concern" doubt poses a substantial risk to their investment. The insurance settlement and debt repayment provide some financial stability but are offset by declining core revenues.
• Creditors: The full repayment and termination of the Senior Secured Credit Facility on September 18, 2025, significantly reduced the company's secured debt obligations, improving its credit profile with remaining creditors.
• Employees: Headcount reductions were implemented as part of cost-saving initiatives, impacting employees. An ongoing employee dispute related to the Grass Valley fire could affect employee morale and lead to potential liabilities.
• Customers: Shifts in product mix and repricing of contract manufacturing agreements may affect customer relationships and volumes. The launch of VLN cigarettes aims to attract new customers focused on harm reduction.
• Suppliers: Cost savings initiatives include pricing strategies employed with raw material suppliers, potentially impacting their relationships and terms with the company.

Next Steps

• Full-scale launch of VLN cigarettes in over 1,700 c-stores expected to begin in Q4 2025.
• Management continues to evaluate strategies for reducing expenses and pursuing financing (debt/equity issuance, asset sales, strategic partnerships).
• Ongoing discovery in the Cookies Retail Products dispute (Count I remains).
• Defense against the employee dispute related to the Grass Valley fire.
• Installment payments due for the 2025 GVB Promissory Note on November 1, 2025, January 1, 2026, and February 1, 2026.

Key Dates

Recommendation

Despite a one-time net income boost from an insurance settlement and the successful repayment of senior secured debt, the company faces severe underlying challenges. Core revenues from continuing operations are in significant decline (down 32.5% in Q3), gross losses are widening, and cash burn from operations increased. The persistent "substantial doubt" about the company's ability to continue as a going concern, coupled with a history of significant shareholder dilution through repeated capital raises and reverse stock splits, indicates a highly precarious financial position. While cost-cutting and the upcoming VLN launch offer some hope, the fundamental business performance is deteriorating, making the stock a high-risk investment with significant downside potential.

Keywords

22nd Century Group, XXII, SEC Filing, 10-Q, Quarterly Report, Tobacco Products, Reduced Nicotine, VLN, MRTP, Contract Manufacturing, Financial Results, Going Concern, Capital Raise, Warrants, Insurance Settlement, Debt Repayment, Operating Loss, Revenue Decline, Share Dilution, Litigation, Corporate Governance, Risk Factors